Correlation of neomycin, faecal neutral and acid sterols with colon carcinogenesis in rats by Panda, S K et al.
Cancer of the large bowel has been the subject of intensive inves-
tigations for many years and its incidence has been found to vary
with geographic area and socioeconomic level (Dolls, 1969). From
the distribution of large bowel cancer in various parts of the world
and data dealing with migrant populations, it is apparent that
environmental factors, rather than genetic and social factors, play
a significant role in the aetiology of colon cancer in man (Haenzel
et al, 1973; Wynder, 1975).
Epidemiological studies including metabolic parameters of role
of diet on colon cancer have revealed that populations consuming
high fat diets have an increased risk of developing colon cancer
compared to populations consuming vegetarian diets (Reddy et al,
1977; Cohen et al, 1978; Reddy, 1992). Animal model studies
have shown that rats fed unsaturated fats developed more tumours
than those fed saturated fats (Broitman et al, 1977; Carroll, 1987).
Epidemiological studies have also shown that high-risk popula-
tions have increased concentrations of intestinal anaerobic bacteria
and their enhanced metabolism of neutral sterols and primary bile
acids in gut (Reddy, 1992; Corpet et al, 1994). The bacterial trans-
formation of cholesterol to coprostanol and coprostanone in the
large bowel was extremely high for the American population,
comprising over 80% of the faecal sterols. Further studies have
indicated that faecal excretions of cholesterol and/or its metabo-
lites and bile acids were higher in patients with colorectal cancer
and adenomatous polyps (Reddy et al, 1977).
Recent studies have implicated polyunsaturated fats rich in
omega-6-polyunsaturated fatty acids (PUFAs) in the increased
incidence of colon cancer (Cannizzo and Broitman, 1989; Lindner,
1991; Narisawa et al, 1991; Reddy, 1992; Narisawa et al, 1994;
Ochiai et al, 1996) and have focused on the possibility that dietary
fats exert a promoter effect subsequent to the initiation of induc-
tion by a carcinogen. The focal point is upon the faecal excretion
of endogenously synthesized neutral and acid sterols, and their
subsequent modification by the gut flora to carcinogens,
promoters or co-carcinogenic agents (Reddy, 1992). Studies from
this laboratory supported the observations that dietary lipid-
induced alterations in the flora increase the production of carcino-
genic metabolites, and that cholesterol metabolism in gut has a key
role to play in this regard (Kraus et al, 1987; Fabricant and
Broitman, 1990; Cerda et al, 1995).
The present study has been designed in an attempt to correlate
the faecal concentration of one or more neutral and acid sterols, to
the incidence of colon tumorigenesis. Neomycin, which is known
to have a significant effect upon sterol metabolism in gut and their
faecal concentration (Sedaghat et al, 1975), has been administered
orally to rats fed polyunsaturated fat (safflower oil) and cholesterol
diets. The influence of neomycin on the location, incidence and
number of large and small bowel tumorigenesis in rats induced by
DMH, and subsequent changes in faecal excretion of neutral and
acid sterols have been investigated.
MATERIALS AND METHODS
Animals and diets
Sprague Dawley CD male weanling rats 30–35 days old, weighing
25–40 g (obtained from Charles River Breeding Laboratories,
MA, USA) were randomized and divided into four groups (viz. I,
I-N, II, II-N). Each group consisted of 20 rats and was fed the
basal diet listed in Table 1 supplemented with the following:
I – 20% safflower oil diet (basal diet);
I-N – 20% safflower oil diet and neomycin sulphate 21 mg%
in drinking water;
II – 20% safflower oil diet, 1% cholesterol and 0.3% cholic
acid;
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II-N – 20% safflower oil diet, 1% cholesterol, 0.3% cholic
acid and neomycin sulphate 21 mg% in drinking water.
Neomycin was administered to rats in two dietary groups, I-N and
II-N, as neomycin sulphate in their drinking water. The drinking
water of the animals in dietary groups I and II did not contain any
neomycin sulphate.
In Western diets, the principal PUFAs that effectively lower
serum cholesterol levels are linoleic (C 18:2) and linolenic (C
18:3) acids. Safflower oil has been used in this experiment because
it is rich in these PUFAs (77.4%). Cholic acid was used in the high
cholesterol diet (II and II-N) in order to maintain a prolonged
hypercholesterolaemia in rats. The vitamin powder and salt
mixture provided the remaining known vitamins and minerals for
adequate maintenance of the animals, and has been used previ-
ously in this laboratory (Broitman et al, 1977). The sucrose level
was adjusted on a weight basis to compensate for addition or omis-
sion of nutrients from the basal diet. The 20% fat diets provided
36% of calories as fat and 4.53 Kcal g–1 diet. After 2 weeks on the
diet, each group received 10 mg kg–1 of DMH dissolved in saline
and injected intramuscularly once each week for 15 weeks. These
were designated ID, IDN, IID and IIDN, respectively, and were
maintained on the diets for an additional 20 weeks following the
last DMH injections.
Animals were housed in individual cages in carefully controlled
quarters at a constant temperature of 70 ± 2°F. They were weighed
twice weekly, and at 2-week intervals stool examinations were
performed to detect gastrointestinal tract bleeding. Food containers
were weighed before and after each filling (on alternate days) to
determine food consumption. Animals that ‘spilled’ diets were not
included in the average for food intake. Animals were checked
daily for physical appearance and moribund animals noted.
Animals that died prior to the termination date were autopsied.
Kidneys, lungs, liver, spleen and testes were removed from all rats
and examined in the gross. The stomach, with the oesophagus
intact, small and large bowel were washed with ice-cold saline and
then formaldehyde, and examined under a 10´ magnification lens
for the presence of lesions. Lesions in the gross were verified by
routine histological procedures, i.e. staining with haematoxylin,
eosin and periodic acid-Schiff stains. The remaining portions of the
hollow viscera in which lesions were not apparent grossly, were
rolled, sectioned and examined histologically.
Serum cholesterol levels
These were determined by the method of Carpenter et al (1957).
Method for quantitation of faecal neutral and acid
sterols
Twenty-four-hour stool output was collected from rats of each
dietary group every 90 days. The faeces were homogenized with a
measured volume of methanol, and subsequently lyophilized. For
quantitation of neutral and acidic sterols, we used the techniques
of Miettinen et al (1965) for neutral sterol analysis, and those of
Grundy et al (1965), Deschner et al (1977) and Raicht et al (1975)
for acid sterol analysis, with modifications made in our laboratory.
The modifications included the addition of [3H(G)] glycocholic
acid (New England Nuclear, Boston, MA, USA) instead of
[24-14C] deoxycholic acid as a recovery standard to each sample at
the beginning of the analysis to correct for incomplete recoveries
during extraction and thin layer chromatography. Since bile acids
are excreted as conjugates in the faeces, the addition of radioactive
bile acid conjugate for the evaluation of recovery was most appro-
priate for precise measurements of these bile acids. The modifica-
tions also included the use of 5b-cholanic acid methyl ester and
coprostanol as internal standards for quantitations of neutral and
acid sterols, respectively, instead of 5a-cholestane. Since 5a-
cholestane comes almost with the solvent peak, its use as an
internal standard in the gas chromatographic analysis of faecal
neutral and acid sterols may lead to erroneous results. 5b-cholanic
acid methyl ester and coprostanol are suitable in this respect, since
they meet all the criteria of internal standard. The methylation
solution for faecal acid sterols before thin layer chromatography
was prepared by the slow addition of freshly distilled acetyl chlo-
ride to 100 ml of lipopure methanol. These were purchased as
instant methanolic HCl kit from Applied Science Laboratories, Inc
(Pennsylvania, USA).
Table 1 Composition of polyunsaturated fat dieta (basal diet)
Constituents Percentage composition of 20% fat diet
Safflower oil 20.0
Casein (vitamin-free) 18.0
Sucrose 51.6
Choline chloride 0.3
Salt mixture (hegsted) 4.0
Vitamin mixture 1.0
Vitamin A, D, E mix 0.1
Alphacel 5.0
100.0
Kcal/g (calculated) 4.53
aSalt mixture (Hegsted) obtained from ICN Pharmaceuticals Inc (Cleveland,
OH, USA). Vitamin composition of diets as reported in Broitman et al (1977).
Table 2 Food consumption in rats fed various dietary regimens with and
without neomycin
Food consumption (g per day)
Dietary group Week 4 Week 16 Week 32
ID 15.0 ± 1.4a 18.7 ± 0.4 18.1 ± 0.6
IDN 18.0 ± 0.7 16.6 ± 1.0 19.1 ± 1.0
IID 21.6 ± 1.7 18.0 ± 1.2 15.5 ± 1.6
IIDN 15.8 ± 1.0 16.0 ± 0.7 21.7 ± 1.4
aFood consumption was measured daily throughout the experiment. Results
depicted represent the mean ± s.e.m. for food consumption of each group on
the week listed.
Table 3 Serum cholesterol levels in rats fed various polyunsaturated fat
diets with and without neomycin
Diet Serum cholesterol
(mg 100 ml–1)
20% Safflower oil 87 ± 11a
20% Safflower oil + neomycin 51 ± 8b
20% Safflower oil + cholesterol + cholic acid 340 ± 63
20% Safflower oil + cholesterol + cholic acid + neomycin 186 ± 20b
aMean ± s.e.m taking five rats per dietary group. bP < 0.025
(t-test) compared to corresponding dietary group without neomycin.1134 SK Panda et al
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Both the neutral and acid sterols were quantitated with a
Hewlett Packard Model 873 gas chromatograph instrument on a
6-foot column packed with 3% ov-101 on 100–120 mesh
Supelcoport. Column temperature was 260°C and that of the inlet
and detector temperature was 280°C. All the analyses were
performed in duplicate leading to more reliable results.
RESULTS
Figure 1 illustrates the weight gained by the rats in different groups
during the course of the study. It is evident that rats on IDN diet
gained significantly more weight than those fed IIDN diet (P <
0.05). Also, an increase in growth rate has been exhibited by rats
on IID diet from those on ID diet (P < 0.05). Within dietary
groups, addition of neomycin to basal diet (ID) has shown an
increase in weight (P < 0.01), while addition of neomycin to high
cholesterol diet (IID) exhibited a decrease in weight (P < 0.05).
Food consumption of animals fed the various diets presented in
Table 2 shows that up to the first 4 weeks, rats on IDN diet
consumed significantly more than those on IIDN diet (P < 0.01).
Same trend has been observed between rats fed high cholesterol
diet and basal diet (IID > ID, P < 0.01). But from 4 to 16 weeks, all
the rats consumed the same amount of food. However, from 16 to
32 weeks, rats fed neomycin with or without cholesterol consumed
more than those fed diets without neomycin (IDN > ID, IIDN >
IID, P < 0.05).
Table 3 illustrates the serum cholesterol levels of rats of
different dietary regimens. It appears that rats fed high cholesterol
diets have significantly increased serum cholesterol levels than
those fed diets without cholesterol (P < 0.01). However, within
each dietary group, addition of neomycin has exhibited a signifi-
cant lowering of serum cholesterol levels (P < 0.025).
Table 4 represents the incidence and numbers of large and small
bowel tumours in DMH-treated rats fed different diets with or
without neomycin. Rats fed the basal diet only (ID) have been
found to have the lowest incidence and smallest number of large
bowel tumours, which has increased on addition of neomycin.
Supplementing the basal diet with cholesterol and cholic acid (IID)
also augmented large bowel tumorigenesis. However, addition of
neomycin to this group reduced the incidence and number of large
bowel tumours. No significant differences were noted in either the
incidence or the number of small bowel tumours among the
groups.
Faecal excretion of neutral and acid sterols in DMH-treated rats
fed various safflower oil diets with and without neomycin (illus-
trated in Table 5) shows significant increase in cholesterol excre-
tion in cholesterol feeding rats than in non-cholesterol feeding
ones (IID > ID, P < 0.01). This trend has also been shown within
cholesterol feeding groups (IIDN > IID, P < 0.01). The concentra-
tion of faecal coprostanol was significantly higher in rats fed 20%
safflower oil and neomycin (IDN) than any other dietary groups
(P < 0.01), and the concentration was found to be least in rats on
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Figure 1 Growth of DMH-administered rats fed various polyunsaturated fat
diets with or without neomycin. ID: 20% safflower oil; IDN: 20% safflower oil
+ neomycin; IID: 20% safflower oil + cholesterol + cholic acid; IIDN: 20%
safflower oil + cholesterol + cholic acid + neomycin. Values are mean 
± s.e.m. starting with 20 rats per dietary group. IDN > IIDN, IID > ID and 
IID > IIDN, P < 0.05. IDN > ID, P < 0.01 (t-test)
Figure 2 Correlation of faecal coprostanol and cholesterol with large bowel
tumorigenesis. l–l: correlation of coprostanol between ID and IDN; l l–l l:
correlation of coprostanol between IID and IIDN; l.....l: correlation of
cholesterol between ID and IDN; l l.....l l: correlation of cholesterol between
IID and IIDN
Table 4 Large bowel and small bowel tumour incidence and average tumour
number in DMH-treated rats fed various polyunsaturated fat diets with and
without neomycin
Diet No. of Incidence of Average no. Incidence of Average no.
rats small bowel of small large bowel of large
tumours bowel tumours bowel
tumours per tumours per
rat rat
ID 20 25% 0.35 ± 0.40 60% 0.90 ± 0.30
IDN 8 25% 0.50 ± 0.20 100%a 3.00 ± 0.20
IID 20 20% 0.35 ± 0.10 100% 3.00 ± 0.70b
IIDN 8 37.5% 0.50 ± 0.20 75%a 1.13 ± 0.30c
aAs compared with corresponding dietary group without neomycin, P < 0.01
(c2 test). bAs compared to dietary group without neomycin and cholesterol,
P < 0.01 (ANOVA). cAs compared to dietary group with neomycin and without
cholesterol, P < 0.01 (ANOVA).IIDN diet. Faecal excretion of cholic acid has been found to be
higher in rats fed high cholesterol diet with neomycin (IIDN) than
in those on other dietary regimens (P < 0.01). The concentration of
deoxycholic acid in the faeces was higher in rats on IID diet than
any other dietary groups (P < 0.01), while faecal excretion of litho-
cholic acid remained almost the same comparing ID with IDN and
IID with IIDN.
From Tables 4 and 5, it is apparent that with increase in number
of tumours on addition of neomycin to the rats fed the basal diet
only (ID), concentration of coprostanol increased significantly
while that of cholesterol decreased (ID vs IDN, P < 0.01).
However, this trend has reversed in the cholesterol-fed groups of
rats, where addition of neomycin to group IID dietary regimen
decreased large bowel tumorigenesis, but concentration of faecal
coprostanol also decreased with increase in faecal cholesterol
concentration (IID vs IIDN, P < 0.01). Thus the positive and nega-
tive correlations of coprostanol and cholesterol, respectively, with
the incidence of large bowel tumorigenesis in rats fed the four
dietary regimens are illustrated in Figure 2.
DISCUSSION
The long-term objective of this laboratory is to identify nutritional
factors that contribute to the high incidence of colon cancer in
Western culture. In the current study, 20% safflower oil diet was
used with or without cholesterol, in order to have a correlation
between dietary cholesterol and large bowel tumorigenesis. Our
early studies utilizing atherogenic diets and DMH for tumour
induction have implied that cholesterol is the key issue, whether it
is retained in systemic and enterohepatic circulation, or removed
and subjected to microbial modification in colon (Broitman et al,
1977; Kraus et al, 1987; Fabricant and Broitman, 1990). Thus,
increasing the quantity of cholesterol to the large bowel by
increased intake of dietary cholesterol might contribute to the
enhanced development of large bowel tumour. The augmentation
of large bowel tumorigenesis on addition of cholesterol to 20%
polyunsaturated fat diet (ID vs IID, P < 0.01, c2 test) in this study
has confirmed the above findings (Table 4).
Lowering of serum cholesterol and shunting it out through the
gut via a hypocholesterolaemic drug has been reported to enhance
colon carcinogenesis. Studies with clofibrate, cholestyramine
(Steiner et al, 1991), neomycin (Broitman et al, 1960; Sedaghat et
al, 1975; Kesaniemi and Miettinen, 1991) etc. have been sugges-
tive enough to promote concern regarding the effects of lowering
serum cholesterol with drugs to the development of gastroin-
testinal tract neoplasms. Many hypolipidaemic agents are associ-
ated with increased faecal bile acids and neutral sterol excretion,
and have serum cholesterol lowering effects. Neomycin is one
such agent which lowers serum cholesterol level and inhibits
cholesterol absorption in colon of man (Kesaniemi and Miettinen,
1991). The data presented in Table 3 show that addition of
neomycin to 20% safflower oil diets with or without cholesterol
has lowered the serum cholesterol levels significantly (ID vs IDN,
IID vs IIDN, P < 0.025, t-test). In our study, addition of neomycin
to 20% safflower oil diet (ID) enhanced the incidence of large
bowel tumours (Table 4). This result is in agreement with earlier
reports suggesting a positive correlation of serum cholesterol-
lowering effect of neomycin with development of colon tumours.
However, there was no change in small bowel tumour numbers
with addition of neomycin to the rats fed basal diet (ID vs IDN).
Although there has been an increase in small bowel tumorigenesis
on addition of neomycin to cholesterol-feeding groups (IID vs
IIDN), the increase was not significant.
It has been difficult to ascertain whether bile acids or neutral
sterols are responsible for augmentation of tumorigenesis. In our
laboratory it is believed that the neutral sterols excreted in the
large-bowel lumen might in some manner augment this process.
The use of neomycin affords a particular advantage in that its
hypocholesterolaemic effect is almost exclusively related to an
increased output of faecal neutral sterols. Thus, it should be
possible to ascertain if increased tumorigenesis occurs in animals
fed neomycin compared to animals not fed neomycin, since
neomycin alters the neutral and acid sterol concentrations in gut
and relates them to alterations of tumour numbers. Such an event
would be associated with increased levels of neutral sterols and
this would implicate neutral sterols as a participant in large bowel
tumorigenesis rather than bile acids. In our experiment, neomycin
enhanced incidence of large bowel tumours significantly (Table 4)
when added to the dietary group ID, which has been accompanied
by a significant increase in faecal coprostanol (Table 5). Thus, our
data could satisfactorily correlate the enhanced excretion of faecal
neutral sterol coprostanol to the augmented large-bowel tumori-
genesis (ID vs IDN, correlation coefficient, r = +1). In the second
dietary group, IID, effect of neomycin apparently did not seem to
show the same pattern with respect to its control. The incidence of
large bowel tumorigenesis was less by 25% (IID vs IIDN,
P < 0.01, c2 test) when neomycin was added to the cholesterol-
supplemented diet (Table 4). Therefore, neomycin augmented
tumorigenesis when the polyunsaturated fat diet contained no
cholesterol, and decreased incidence of large bowel tumours when
the same diet was supplemented with cholesterol. This indicated a
complex interaction of neomycin with the cholesterol metabolism
in gut. Presence of neomycin in conjunction with dietary choles-
terol might have some regulatory role to play in inhibiting large
Neomycin, faecal coprostanol and colon tumorigenesis 1135
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Table 5 Faecal excretion of neutral and acid sterols in DMH-treated rats fed various dietary regimens with and without neomycin
Faecal neutral sterols (mg g–1 dry weight) Faecal acid sterols (mg g–1 dry weight)
Diet No. of rats Cholesterol Coprostanol Total Cholic Deoxycholic Lithocholic Total
ID 4 6.19 ± 2.89d 1.36 ± 0.30 7.55 ± 3.07 1.08 ± 0.76 1.99 ± 1.45 0.56 ± 0.30 3.63 ± 2.43
IDN 7 3.14 ± 0.46 3.13 ± 0.73c 6.27 ± 0.41 0.21 ± 0.07 0.73 ± 0.14 0.53 ± 0.06 1.47 ± 0.18
IID 7 46.82 ± 2.07a 1.57 ± 0.89 49.40 ± 2.81a 5.85 ± 3.09 12.43 ± 3.02 3.00 ± 0.92 a 21.28 ± 0.83a
IIDN 4 72.51 ± 1.70a,b 0.00c,e 72.1 ± 1.70a,b 31.94 ± 5.72b 0.00e 2.14 ± 0.62a 34.08 ± 5.14a,b
aAs compared to dietary groups without cholesterol, P < 0.01 (ANOVA). bAs compared to dietary group without cholesterol, P < 0.01 (t-test). cAs compared to
dietary groups without neomycin, P < 0.025 (t-test). dMean ± s.e.m. ePeak non-detectable in the gas chromatogram.1136 SK Panda et al
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bowel tumorigenesis in rats. This might be possible either by
altering the sterol metabolism in gut, or by making cholesterol
unavailable to the large bowel lumen by inhibiting its absorption in
colon or by feedback inhibition of cholesterol synthesis in gut. The
exact mechanism is yet to be established. The large bowel flora
might have an important role to play in this regard.
From the faecal excretion data (Table 5), it has been found that
faecal cholesterol levels were always less in each dietary group
where there were more tumours. Thus, the amount of faecal
cholesterol has a negative correlation with tumour number (corre-
lation coefficient, r = –1). However, faecal coprostanol excretion
was consistently high when there were more tumours, which was
satisfactorily shown in Figure 2. These observations could give
credence to the concept developed by earlier workers (Reddy et al,
1977; Carroll, 1987; Reddy, 1992) that due to the dietary lipid-
induced alteration of the faecal flora, the sterols modified in gut
might act as carcinogens or co-carcinogens. Thus, enhanced faecal
excretion of coprostanol and diminished excretion of faecal
cholesterol with augmented large bowel tumorigenesis in this
study might imply increased activity of the intestinal flora in trans-
formation of cholesterol and/or its metabolites in gut. Like choles-
terol, cholic acid also showed negative correlation with large
bowel tumorigenesis. The reason could not be ascertained satisfac-
torily. Cholic acid might have contributed to the bile acid pool in
the animals. There is no evidence that cholic acid may act as a
promoter or co-carcinogen. The concentrations of the secondary
bile acids, deoxycholic and lithocholic acids did not seem to
contribute to large bowel tumorigenesis, as shown in the data in
Table 5.
In view of the above findings, it can be concluded that, in DMH-
fed rats fed polyunsaturated fat diets supplemented with neomycin
and cholesterol, coprostanol might have some contributions in
augmenting large bowel tumorigenesis. All other neutral and
acidic sterols seem to have no participation. The probable role of
coprostanol might be taken as an important factor, and regulation
of cholesterol metabolism in gut and variations in bacterial popula-
tion responsible for the alteration of the faecal sterols might
provide some preliminary insight in prevention of colon cancer.
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